These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 11083703

  • 21. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG, Muluk NB, Kar M, Cingi C.
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [Abstract] [Full Text] [Related]

  • 22. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
    Macy E, Bernstein JA, Castells MC, Gawchik SM, Lee TH, Settipane RA, Simon RA, Wald J, Woessner KM, Aspirin Desensitization Joint Task Force.
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
    [Abstract] [Full Text] [Related]

  • 23. Aspirin-sensitive rhinosinusitis and asthma.
    Kowalski ML.
    Clin Allergy Immunol; 2007 Feb; 19():147-75. PubMed ID: 17153012
    [No Abstract] [Full Text] [Related]

  • 24. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y, Shimoda T, Tomari SY, Mitsuta K, Kawano T, Matsuse H, Kohno S.
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [Abstract] [Full Text] [Related]

  • 25. Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis.
    Bochenek G, Bánska K, Szabó Z, Nizankowska E, Szczeklik A.
    Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):1-11. PubMed ID: 14561202
    [Abstract] [Full Text] [Related]

  • 26. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
    Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, Akiyama K.
    Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219
    [Abstract] [Full Text] [Related]

  • 27. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
    Higashi N, Taniguchi M, Mita H, Kawagishi Y, Ishii T, Higashi A, Osame M, Akiyama K.
    J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
    [Abstract] [Full Text] [Related]

  • 28. Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Diagnostic and physiopathological implications.
    Ameisen JC, Capron A, Joseph M, Maclouf J, Vorng H, Pancré V, Fournier E, Wallaert B, Tonnel AB.
    Int Arch Allergy Appl Immunol; 1985 Feb; 78(4):438-48. PubMed ID: 3934085
    [Abstract] [Full Text] [Related]

  • 29. Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics.
    Volkman JA, Pontikes PJ.
    Ann Pharmacother; 2002 Sep; 36(9):1457-61. PubMed ID: 12196067
    [Abstract] [Full Text] [Related]

  • 30. Aspirin-induced asthma: advances in pathogenesis and management.
    Szczeklik A, Stevenson DD.
    J Allergy Clin Immunol; 1999 Jul; 104(1):5-13. PubMed ID: 10400832
    [Abstract] [Full Text] [Related]

  • 31. A new insight into aspirin-induced asthma.
    Jawien J.
    Eur J Clin Invest; 2002 Feb; 32(2):134-8. PubMed ID: 11895461
    [Abstract] [Full Text] [Related]

  • 32. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
    Simon RA.
    Curr Allergy Asthma Rep; 2004 Jan; 4(1):17-24. PubMed ID: 14680616
    [Abstract] [Full Text] [Related]

  • 33. [Asthma and aspirin].
    Schiappoli M, Gani F, Frati F, Marcucci F, Senna G.
    Recenti Prog Med; 2003 Feb; 94(2):79-87. PubMed ID: 12908375
    [Abstract] [Full Text] [Related]

  • 34. Leukotrienes as mediators of airway obstruction and inflammation in asthma.
    Dahlén B, Dahlén SE.
    Clin Exp Allergy; 1995 Nov; 25 Suppl 2():50-4. PubMed ID: 8590344
    [No Abstract] [Full Text] [Related]

  • 35. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management.
    Szczeklik A, Stevenson DD.
    J Allergy Clin Immunol; 2003 May; 111(5):913-21; quiz 922. PubMed ID: 12743549
    [Abstract] [Full Text] [Related]

  • 36. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA, Warner TD, Vojnovic I, Del Soldato P, Parikh A, Scadding GK, Mitchell JA.
    Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
    [Abstract] [Full Text] [Related]

  • 37. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
    Mastalerz L, Sanak M, Gawlewicz-Mroczka A, Gielicz A, Cmiel A, Szczeklik A.
    Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
    [Abstract] [Full Text] [Related]

  • 38. Mechanisms of aspirin sensitivity.
    Picado C.
    Curr Allergy Asthma Rep; 2006 May; 6(3):198-202. PubMed ID: 16579869
    [Abstract] [Full Text] [Related]

  • 39. COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease.
    Crofford LJ.
    Arthritis Res Ther; 2003 May; 5(1):25-7. PubMed ID: 12716444
    [Abstract] [Full Text] [Related]

  • 40. Challenge of isolated sputum cells supports in vivo origin of intolerance reaction to aspirin/non-steroidal anti-inflammatory drugs in asthma.
    Higashi A, Kumlin M, Higashi N, Daham K, Gaber F, Lindeberg A, James A, Skedinger M, Delin I, Gyllfors P, Dahlén SE, Dahlén B.
    Int Arch Allergy Immunol; 2012 May; 158(3):299-306. PubMed ID: 22398682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.